Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 801–900 of 1,005
Hernández-Martín, M., Macho‐González, A., Garcimartín, A., López‐Oliva, M. E., Bocanegra, A., Redondo‐Castillejo, R., Bastida, S., Benedí, J., & Sánchez-Muniz, F. J. (2024) · Food & Function · doi:10.1039/d3fo04103d · Cited by 10
Suanrueang, P. (2024) · Scientific Reports · doi:10.1038/s41598-023-49274-z · Cited by 10
“One of the benefits of walking is that it has the potential to induce skeletal muscle cell activities to provoke increasing glucose absorption in the blood flow from plasma into the muscle 41 .”
BackgroundBhilare, N. V., Shedge, R., Tambe, P. M., & More, A. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03187-2 · Cited by 10
Raut, S. S., Acharya, S., Deolikar, V., & Mahajan, S. N. (2024) · Cureus · doi:10.7759/cureus.53279 · Cited by 16
Videla, L. A., Valenzuela, R., Zúñiga‐Hernández, J., & del Campo, A. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400062 · Cited by 11
Albadri, A. M. E., & Al-Diwan, J. K. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_210_22 · Cited by 13
Decoding the Gut Microbiota–Gestational Diabetes Link: Insights from the Last Seven Years
Balleza-Alejandri, L. R., Peña-Durán, E., Beltrán-Ramírez, A., Reynoso-Roa, A. S., Sánchez-Abundis, L. D., García-Galindo, J. J., & Suárez-Rico, D. O. (2024) · Microorganisms · doi:10.3390/microorganisms12061070 · Cited by 13
“Emerging research highlights the significant role of gut microbiota dysregulation alongside adipokine imbalance and inflammation in its pathogenesis [8].”
BackgroundPipatpiboon, N., Koonrungsesomboon, N., Suriyawong, W., Sripetchwandee, J., & Turale, S. (2022) · Nursing and Health Sciences · doi:10.1111/nhs.12922 · Cited by 10
Wasner, H. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042200 · Cited by 12
“The progression of insulin resistance is connected to a decreasing receptor density [33,34].”
BackgroundBensaad, M. S., Dassamiour, S., Hambaba, L., Bensouıcı, C., Karima, O., & Kahoul, M. A. (2021) · Herba Polonica · doi:10.2478/hepo-2021-0023 · Cited by 14
“Type 2 diabetes is one of the most dangerous illnesses of current decade, which may be the result of several factors like mitochondrial or pancreatic β-cell dysfunction, insulin resistance, and impaired glucose tolerance [52].”
BackgroundLin, P., Tsai, C.-S., Hsu, C.-C., Lee, I., Shen, Y., Fan, H., Chen, Y., Tu, L., & Liu, W.-M. (2022) · Talanta · doi:10.1016/j.talanta.2022.124130 · Cited by 11
Rahat, S. T., Mäkelä, M., Nasserinejad, M., Ikäheimo, T. M., Hyrkäs-Palmu, H., Valtonen, R. I. P., Röning, J., Sebert, S. P., Nieminen, A. I., Ali, N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087507 · Cited by 15
Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review
Karkhaneh, L., Tabatabaei‐Malazy, O., Bandarian, F., Mohseni, S., & Larijani, B. A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00908-x · Cited by 11
Toward Development of a Diabetic Synovium Culture Model
Sakhrani, N., Lee, A. J., Murphy, L. A., Kenawy, H. M., Visco, C. J., Ateshian, G. A., Shah, R. P., & Hung, C. T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.825046 · Cited by 9
Malenica, M., Klisic, A. N., Meseldžić, N., Dujić, T., Bego, T., & Kotur‐Stevuljević, J. (2022) · Journal of Medical Biochemistry · doi:10.5937/jomb0-39636 · Cited by 12
A review of the last decade: pancreatic cancer and type 2 diabetes
Wu, J., Tang, L., Zheng, F., Chen, X., & Li, L. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2252204 · Cited by 9
“…this highlights the importance of studying the relationship between Pc and t2DM, understanding the impact of glycemic control on Pc development, and exploring molecular expressions associated with these conditions (Sciacca et al. 2013, li et al. 2019, Galicia-Garcia et al. 2020, lin et al. 2020).”
Lin, D., Yu, J., Lin, L., Ou, Q., & Quan, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-43438-7 · Cited by 10
Ji, L., Yang, X., Jin, Y., Li, L., Yang, B., Zhu, W., Xu, M., Wang, Y., Wu, G., Luo, W., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166900 · Cited by 11
Li, B., Li, X., Zeng, Y., Zhou, Z., Zhao, D., Qin, F., Zhang, B., Yao, W., Mao, Y., Zhou, L., et al. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2278082 · Cited by 9
“T2DM is a heterogeneous chronic metabolic disorder caused by insulin resistance or deficiency, and its principal manifestation is hyperglycemia or hyperlipidemia (Galicia-Garcia et al., 2020).”
Yılmaz, B., Sîrbu, A., Başar, H. B. A., Gökşen, G., Chabı, I. B., Kumagaı, H., & Özoğul, F. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2292790 · Cited by 10
“The pathogenesis of T2DM is not fully understood although it has been stated that T2DM results from the combination of two factors which are insufficient insulin release by pancreatic β-cells and improper insulin response in insulin-sensitive tissues (Galicia-Garcia et al. 2020).”
Mai, A. S., Tan, B. J., Sun, Q.-Y., & Tan, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020561 · Cited by 9
“As compared with T2DM—which occurs due to insulin resistance and shares a close link with metabolic syndrome [11]—T1DM is an entirely different disorder that is hallmarked by the autoimmune destruction of insulin-secreting pancreatic islet beta cells [12].”
BackgroundSuaifan, G. A. R. Y., Alkhawaja, B. A., Shehadeh, M. B., Sharma, M., Kuan, C. H., & Okechukwu, P. N. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00647f · Cited by 10
Diabetes and Risk of Surgical Site Infection: A Narrative Review
Arshad, S., Rasul, A., Batool, M., Zukhruf, Z., & Asad, M. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i1.500 · Cited by 22
El-Hameed, A. M. A., Eskandrani, A. A., Abdel-Reheim, E. S., Abdel‐Moneim, A., & Addaleel, W. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102029 · Cited by 12
Al‐Azzam, N. Z., Elsalem, L., Mousa, B. M. A., & Saadeh, N. A. (2024) · BIO Integration · doi:10.15212/bioi-2024-0005 · Cited by 10
Jiang, R., Cong, Z., Zheng, L., Zhang, L., Guan, Q., Wang, S., Fang, J., Chen, J., & Liu, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1401070 · Cited by 10
SGLT2 Inhibitors and Uric Acid Homeostasis
Zapf, A. M., & Woodward, O. M. (2024) · Gout Urate and Crystal Deposition Disease · doi:10.3390/gucdd2020014 · Cited by 10
“Metabolic disorders and disorders in insulin regulation/response can lead to dysfunction in circulating glucose levels and glucose storage, increasing plasma glucose levels above normal, resulting in the clinical pathology of hyperglycemia [31].”
BackgroundMizani, M. A., Dashtban, A., Pasea, L., Zeng, Q., Khunti, K., Valabhji, J., Mamza, J. B., Gao, H., Morris, T., & Banerjee, A. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004191 · Cited by 16
Pescariu, S. A., Elagez, A., Nallapati, B., Bratosin, F., Bucur, A., Negru, A. G., Gaiţă, L., Citu, I. M., Popa, Z. L., & Barata, P. I. (2024) · Pharmaceuticals · doi:10.3390/ph17070929 · Cited by 10
Ameliorative Effects of Essential Oils on Diabetes Mellitus: A Review
Barbhuiya, P. A., Pariong, D., Alam, A. P., Mazumder, T. M. S. R., Sarma, S., Sen, S., & Pathak, M. P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266314922240822091215 · Cited by 10
Fakhrolmobasheri, M., Shafie, D., Manshaee, B., Karbasi, S., Mazroui, A., Najafabadi, M. M., Mazaheri‐Tehrani, S., Sadeghi, M., Roohafza, H., Emamimeybodi, M., et al. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0269 · Cited by 10
“Abnormal tissue response to hormonal stimuli, mitochondrial dysfunction, and endothelial dysfunction are associated with the pathophysiology of T2DM (2).”
Hu, M., Numonov, S., Aisa, H. A., & Xin, X. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105257 · Cited by 11
Ali, Z., Ayub, A., Lin, Y., Anis, S., Khan, I., Younas, S., Tahir, R. A., Wang, S., & Li, J. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101130 · Cited by 11
“Alternatively, in T2DM, understanding metabolic variables and communication pathways that control b -cell proliferation is critical for therapeutic approaches [1].”
InfluentialNisar, M. F., Li, M., Xu, J., & Wan, C. C. (2024) · Frontiers in Marine Science · doi:10.3389/fmars.2024.1438955 · Cited by 12
Chen, Q. H., Yang, Y., Xu, J., Wang, J., Fang, T., Yuan, Y., Wang, C., & Zhang, L. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.11.013 · Cited by 10
Li, Q., Xu, Y.-X., Lu, X., Shen, Y., Wan, Y., Su, P., Tao, F., Chen, X., & Sun, Y. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117589 · Cited by 11
Putranata, H., Hengky, A., & Hartoko, B. (2025) · Acta Diabetologica · doi:10.1007/s00592-024-02440-9 · Cited by 10
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic condition caused by insulin resistance and relative insulin insufficiency, resulting in hyperglycemia [ 1].”
PFKFB3 Connects Glycolytic Metabolism with Endothelial Dysfunction in Human and Rodent Obesity
Batori, R. K., Bordán, Z., Padgett, C. A., Huo, Y., Chen, F., Atawia, R. T., Lucas, R., Ushio‐Fukai, M., Fukai, T., de Chantemèle, E. J. B., et al. (2025) · Antioxidants · doi:10.3390/antiox14020172 · Cited by 12
“It is well known that a complex interplay of factors contributes to the pathophysiology of endothelial dysfunction in T2D, including hyperglycemia, as well as inflammatory cytokines, such as TNF-α [76].”
Sampath, K. K., Yan, A., & Brownie, S. M. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.02.008 · Cited by 10
Huang, H., Zhao, T., & Ma, W. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.015 · Cited by 9
Exploring the Molecular Pathways Underlying the Anti‐Diabetic Effects of Millets
Kumar, A., Shah, N. N., Chorawala, M. R., Kaushik, R., Prajapati, B. G., & Mehra, R. (2025) · Food Safety and Health · doi:10.1002/fsh3.70007 · Cited by 10
Dehzad, M. J., Raja, A., Moghdani, Z., Sohrabi, Z., Fararouei, M., Famouri, M. L., Askarpour, M., & Babajafari, S. (2025) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2025.30.2.120 · Cited by 14
Zhang, Q., Liao, J., Liu, Z., Song, S., Tian, L., & Wáng, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565158 · Cited by 16
Glabridin Alleviates Metabolic Disorders in Diet‐Induced Diabetic Mice
Yang, X., Lai, K., Zhang, J., Chen, Z., Ding, W., Jiang, Y., & Liu, Y. (2025) · Phytotherapy Research · doi:10.1002/ptr.8517 · Cited by 9
“Type 2 diabetes mellitus (T2DM) is characterized by impaired pancreatic β-cell function and insulin resistance (IR), leading to hyperglycemia and excessive glucagon production (Galicia-Garcia et al. 2020).”
Adiponectin: its role in diabetic and pancreatic cancer
Kumari, S., Peela, S., Srilatha, M., Girish, B. P., & Nagaraju, G. P. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101370 · Cited by 9
Naseem, S., & Rizwan, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112285 · Cited by 11
Cui, Y., Li, F., Li, T., Sun, W., Shi, H., & Cheng, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1521168 · Cited by 9
“IR, a key pathophysiological feature of T2DM, often precedes the clinical diagnosis, with newly diagnosed individuals frequently presenting with IR-related complications (32).”
RetractedTian, X., Wang, L., Zhang, L., Chen, X., Wang, W., Zhang, K., Ge, X., Luo, Z., Zhai, X., & Shao, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-02682-5 · Cited by 17
“Overall, the molecular mechanisms underlying the development of T2DM and its progression to irreversible organ damage remain elusive (76).”
El-Nasr, N. M. E. A., Hussien, Y. A., Elbaset, M. A., Shabana, M. E.-A., & Saleh, D. O. (2025) · Scientific Reports · doi:10.1038/s41598-025-06263-8 · Cited by 9
Type 2 Diabetes Mellitus and bladder cancer: A narrative review on associated signaling pathways
Agostini, L. D. C., & da Silva, G. N. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101381 · Cited by 11
Diabetes and COVID-19: The Vicious Cycle of a Dual Burden
Sen, A., Kumar, D., & Anand, P. (2025) · Outbreak Management and Response · doi:10.1080/29947677.2025.2539083 · Cited by 9
Wang, Z., Dong, Y., Bai, Y.-Y., Zhang, J.-T., Wang, L., Ren, S., Li, X., Hu, J., & Li, W. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500703 · Cited by 12
Alhowail, A. H., Aldawsari, M. F., & Aldubayan, M. A. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s525690 · Cited by 10
Chakravarthy, M. V., Elliott, M. A., Acosta, L., Sonnenberg, G. E., Bialonczyk, D., Wu, J., ARGÜELLES-TELLO, F. A., Garcia‐Reza, R., González‐González, J. G., Hansen, S. K., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70006 · Cited by 11
Pharmacotherapeutic potential of daidzein: insights into mechanisms and clinical relevance
Chinchu Praisthy, L. J., Kushwah, R., Dubey, S., Kumar, V., & Jain, S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01891-y · Cited by 14
Wang, D., Zhang, J., Yang, X., Zhang, Q., Hu, X., Lu, X., Li, H., Bai, X. L., Zhang, K., Sack, M. N., et al. (2025) · Advanced Science · doi:10.1002/advs.202508991 · Cited by 15
Qiu, Z., & Shang, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100418 · Cited by 9
“Conventional theories have attributed primarily β -cell dysfunction to peripheral metabolic disturbances, particularly obesity-associated lip-otoxicity and hyperglycemia [4 – 6].”
Yu, X., Li, M., & Li, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118846 · Cited by 14
Blasio, M. J. D., & Ritchie, R. H. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01274-y · Cited by 10
“…mouse models of angiotensin II-induced hypertensive cardiomyopathy, fenofibrate therapy limited cardiac inflammation (via reductions in tumour necrosis factor (TNF), IL-1β and CXC-motif chemokine 13 signalling) and improved cardiac remodelling and cardiac function by unknown mechanisms 177,204 .”
Sun, X., & Liu, N. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110219 · Cited by 9
Recent Advances in Noncoding RNAs
Tutar, L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98151 · Cited by 10
Sadowska‐Krępa, E., Gdańska, A., Přidalová, M., Rozpara, M., & Grabara, M. (2022) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.01963 · Cited by 10
Alfheeaid, H. A., Alhowail, A. H., Ahmed, F., Zaki, A. K. A., & Alkhaldy, A. A. (2023) · Brain Sciences · doi:10.3390/brainsci13020165 · Cited by 12
Role of DNA methylation in diabetes and obesity
Chu, D., Bui, N.-L., Thị, H. V., & Thi, Y.-V. N. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.01.008 · Cited by 10
Elekofehinti, O. O. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101202 · Cited by 9
Erfanian, S., Mir, H., Abdoli, A., & Roustazadeh, A. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01477-z · Cited by 10
“T2DM is a common metabolic disorders mainly caused by two mechanisms: reduced insulin secretion by pancreatic B cells or resistance of target tissues to insulin [2].”
BackgroundEspinoza-Hernández, F. A., Moreno-Vargas, A. D., & Andrade‐Cetto, A. (2023) · Plants · doi:10.3390/plants12102014 · Cited by 10
“Both proinflammatory cytokines and reactive oxygen species (ROS) induce an altered response in insulin signaling that progresses to IR [6].”
BackgroundKonadu, B. D., Cox, C. K., Garrett, M. R., & Gibert, Y. (2022) · iScience · doi:10.1016/j.isci.2023.107063 · Cited by 11
“It plays an insulin-independent role in glucose sensing and homeostasis,(19) whereas insulin primarily promotes GLUT4 transfer and improves glucose absorption across the plasma membrane of muscle and adipose tissue membrane.(20) When insulin is withdrawn, the amount of GLUT4 on the plasma membrane decreases and the ra…”
BackgroundFagihi, M. H. A., Premathilaka, C., O’Neill, T., Garrè, M., & Bhattacharjee, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c02482 · Cited by 10
Kamran, S. H., Ahmad, M., Ishtiaq, S., Ajaib, M., Razashah, S. H., & Shahwar, D. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116963 · Cited by 11
Recent Trends in the Antidiabetic Prominence of Natural and Synthetic Analogues of Aurones
Rammohan, A., Mukherjee, A., Zyryanov, G. V., Majee, A., & Santra, S. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100533 · Cited by 9
“In general, type-II DM is very common, and it is induced by lifestyle habits and hereditary factors [5].”
BackgroundSwain, S. K., Dash, U. C., Kanhar, S., & Sahoo, A. K. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110999 · Cited by 14
Zhou, J., Zhang, M., Ju, X., Wang, H., Xiao, H., Zhai, Z., Zhong, X., & Hong, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-54496-w · Cited by 9
“Previous studies have demonstrated that chronic low-grade inflammation induced by adipose tissue expansion and obesity leads to insulin resistance, impaired insulin secretion, and ultimately, hyperglycemia 4,39,40 .”
BackgroundXia, W., Yu, H., & Wen, P. (2024) · International Wound Journal · doi:10.1111/iwj.14841 · Cited by 9
RetractedPokharel, D. R., Maskey, A., Kafle, R., Batajoo, A., Dahal, P., Raut, R., Adhikari, S., Manandhar, B., & Manandhar, K. D. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.07.001 · Cited by 14
“These conditions are associated with insulin resistance and/or impaired insulin secretion, which results in persistent hyperglycemia and associated acute and chronic complications [1].”
BackgroundSergi, D., Melloni, M., Passaro, A., & Neri, L. M. (2024) · Nutrients · doi:10.3390/nu16193243 · Cited by 10
“Indeed, T2DM is a multisystem disease and represents a risk factor for a plethora of diseases, including cardiovascular disease, neurodegenerative disorders [23] and several types of cancer [24–26], including BC [27,28].”
BackgroundAlhujaily, M. M., Mir, R., Mir, R., Alghamdi, M. A. A., Wani, J. I., Sabah, Z. U., Elfaki, I., Alnour, T. M. S., Jeelani, M., Abomughaid, M. M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040639 · Cited by 8
“T2DM is caused by the impaired peripheral insulin action in the liver, muscles and adipose tissues as well as by pancreatic beta cell demise [20,41].”
BackgroundAlqudah, M., Khanfar, M., Alfaqih, M. A., Al-Shboul, O. A., Al-U'datt, D. G. F., Al‐Dwairi, A., & Allouh, M. Z. (2022) · Biomedical Reports · doi:10.3892/br.2022.1537 · Cited by 11
MiR-702-5p ameliorates diabetic encephalopathy in db/db mice by regulating 12/15-LOX
Tu, Y., Chen, Q., Guo, W., Xiang, P., Huang, H., Fei, H., Chen, L., Yang, Y., Peng, Z., Gu, C., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114212 · Cited by 11
Protein Targeting to Glycogen (PTG): A Promising Player in Glucose and Lipid Metabolism
Deng, X., Wang, C., Xia, Y., & Yuan, G. (2022) · Biomolecules · doi:10.3390/biom12121755 · Cited by 10
“Under the influence of genetic and/or environmental factors, the decrease of insulin secretion or the disturbance of signal transduction (insulin resistance) will lead to the decrease of energy supply from glucose sources and the enhancement of lipid decomposition and release, and can stimulate liver gluconeogenesis,…”
BackgroundMandal, S. P., Faizan, S., Raghavendra, N. M., & Kumar, B. R. P. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10571-w · Cited by 9
Amadou, C., Heude, B., de Lauzon‐Guillain, B., Lioret, S., Descarpentrie, A., Ribet, C., Zins, M., & Charles, M.-A. A. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101414 · Cited by 10
Ramírez‐Coronel, A. A., Alhilali, K. A. A., Ahmed, Y. B., Almalki, S. G., & Karimian, J. (2023) · Phytotherapy Research · doi:10.1002/ptr.7918 · Cited by 12
Yang, C., Liu, H., Xie, Z., Yang, Q., Du, L., & Xie, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115287 · Cited by 14
Khan, M. U., Mubeen, M., Chohan, H. K., Jawed, S., Jamal, A., Qamar, J. A., Chohan, M. K., Siddiqui, A. A., Anwar, A., & Hashmi, A. A. (2023) · Cureus · doi:10.7759/cureus.46178 · Cited by 9
Miranda, O., Fan, P., Qi, X., Wang, H., Brannock, D., Kosten, T. R., Ryan, N. D., Kirisci, L., & Wang, L. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111066 · Cited by 12
“Dysregulation of glucose metabolism appears to be an early event which precedes other clinical abnormalities, including systemic inflammation, dyslipidemia, and other cardiovascular diseases (Galicia-Garcia, 2020).”
BackgroundJebari‐Benslaiman, S., Larrea, A., Benito‐Vicente, A., & Martı́n, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087659 · Cited by 9
“In this context, Unai Galicia-Garcia et al. provide a comprehensive overview of the pathophysiology of type 2 diabetes mellitus (T2D) and its relationship with cardiovascular disease.”
BackgroundInfluentialSelf-citationAhmad, R., Nnamdi, O. A., Etando, A., Sharma, P., Sinha, S., Chowdhury, K., Rowaiye, A. B., Akter, S., Mou, T. J., Dhingra, S., et al. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.142387 · Cited by 17
Liu, F., Wang, S., Guo, X., Ye, Z.-X., Zhang, H., & Li, Z. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.632 · Cited by 9
Jovicic, N., Andjic, M. M., Novakovic, J. N., Jeremic, N. S., Zivkovic, V. I., Srejovic, I. M., Stanojević, D., Ristić, P., Bolevich, S., & Jakovljevic, V. L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18725 · Cited by 11
“The exact cause of T2DM is unknown, but hereditary factors, lifestyle, and numerous associated diseases and conditions are believed to play an important role in its development [2,3].”
BackgroundRyu, H., Jeong, H. H., Lee, S., Lee, M., Kim, M., & Lee, B. (2023) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2309.09037 · Cited by 8
Mujammami, M. H., Aleidi, S. M., Buzatto, A. Z., Alshahrani, A. S., AlMalki, R. H., Benabdelkamel, H., Dubayee, M. A., Li, L., Aljada, A., & Rahman, A. M. A. (2023) · Pharmaceuticals · doi:10.3390/ph16121717 · Cited by 11
“T2DM is a very common disease worldwide, and more than 700 million people are predicted to have diabetes by 2045 [2].”
BackgroundGonzález, I., Lindner, C., Schneider, I., Díaz-Bautista, E., Morales, M. A., & Rojas, A. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i2.154 · Cited by 14
Sikhayeva, N. S., Bolatov, A. K., Zholdybayeva, E. V., Akhmetollayev, I. A., & Iskakova, A. N. (2024) · Genes · doi:10.3390/genes15060669 · Cited by 8
Gao, Y., Wu, Y., Tie, F., & Wang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32007 · Cited by 8
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from a complex interplay of various contributing factors [1].”
BackgroundJeong, Y., Lee, B. J., Hur, W., Lee, M. J., & Han, S. (2024) · Metabolites · doi:10.3390/metabo14070371 · Cited by 9
“Despite epidemiological studies showing an association between inflammation and T2DM, or obesity, little is known about the exact underlying pathophysiological mechanisms [9,10].”
BackgroundChowdhury, M. R., Kumar, V., & Deepa, V. S. (2024) · Journal of Proteins and Proteomics · doi:10.1007/s42485-024-00157-5 · Cited by 12
“Alzheimer's disease (AD) and Type 2 Diabetes Mellitus (T2DM) represent significant global health challenges, impacting millions worldwide (Jellinger 1998; Galicia-Garcia et al. 2020; Vejandla et al. 2024).”
Brígido, J. A., da Rosa, W. L. D. O., & Lund, R. G. (2024) · Gerodontology · doi:10.1111/ger.12777 · Cited by 9
Sardar, M. B., Raza, M., Fayyaz, A., Nadir, M. A., Nadeem, Z. A., & Babar, M. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09913-x · Cited by 10
“Multiple mechanisms lead to the formation of risk factors that can potentially culminate in CVD. Insulin resistance, defined as the impaired physiologic response of biological tissues to stimulation by insulin [19], is a major cause of both T2DM [20] and CVD [21, 22].”
Młodzik-Czyżewska, M. A., Szwengiel, A., & Chmurzyńska, A. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.10.036 · Cited by 8
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.